Table 2.
Prospective studies investigating new preparative regimens for allogeneic transplantation to treat acute myelogenous leukemia in adults
TMI indicates total marrow irradiation; AML, acute myelogenous leukemia; MDS, myelodysplastic syndrome; HSCT, hematopoietic stem cell transplant; NK, natural killer; IL-2, interleukin- 2; TBI, total body irradiation; GVHD, graft-versus-host disease; and SCT, stem cell transplant.
